Mark Sobczak Named a 2019 Fellow of the American College of Radiology

June 19, 2019

PHILADELPHIA (June 19, 2019)— Mark Sobczak, MD, FACR, clinical director in the Department of Radiation Oncology at Fox Chase Cancer Center, was selected as a 2019 Fellow of the American College of Radiology (ACR).

The ACR Fellowship is a highly selective honor that recognizes a history of service to the ACR, radiation oncology, teaching, and research. Sobczak is one of only eight radiation oncologists in the United States to receive this recognition this year. Fewer than ten percent of radiation oncologists and radiologists have been selected as ACR Fellows since the award was first given in 1924.

Sobczak is recognized for his expertise in treating kidney, bladder, prostate, testicular, ureteral, and urethral cancers. His clinical practice includes intensity modulated radiation therapy, image guided therapy, brachytherapy, and other forms of radiotherapy. Among other professional honors, he has been recognized as a Philadelphia magazine Top Doctor for 2017, 2018, and 2019, and a 2018 Main Line Health Top Doc.

The new class of ACR Fellows was honored in Washington, DC, at a ceremony on May 19, 2019.

Fox Chase Cancer Center (Fox Chase), which includes the Institute for Cancer Research and the American Oncologic Hospital and is a part of Temple Health, is one of the leading comprehensive cancer centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase is also one of just 10 members of the Alliance of Dedicated Cancer Centers. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence five consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. It is the policy of Fox Chase Cancer Center that there shall be no exclusion from, or participation in, and no one denied the benefits of, the delivery of quality medical care on the basis of race, ethnicity, religion, sexual orientation, gender, gender identity/expression, disability, age, ancestry, color, national origin, physical ability, level of education, or source of payment.


For more information, call 888-369-2427

Connect with Fox Chase